Boehringer Ingelheim Vetmedica, Inc.

Vetera - Model 4XP + WNV - Encephalomyelitis Influenza West Nile Virus Vaccine Brochure

Protects against EIV, EEE, WEE, tetanus and West Nile virus in 1 mL dose. At least six-month duration of immunity against equine influenza (Ohio/03). Ohio/03 (Florida Clade 1), Kentucky/95, and Richmond/07 (Florida Clade 2) equine influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza. At least 12-month WNV DOI. Contains equine origin 2005 West Nile virus isolate (E159®). Incorporates the Carbimmune® adjuvant formulation to optimize vaccine performance and minimize reactions. Unique Ultrafil® Purification Technology purification process and adjuvant formulation minimizes non-relevant protein presented to the immune system. Available in single dose pre-filled syringes or color-coded 10 dose vials. Safe for use in horses as young as 4 months of age, including pregnant broodmares

Most popular related searches

Contact supplier

Drop file here or browse